At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5,271 enrolled
Drug / intervention
linezolid (Zyvox) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Outcomes Among a National Veterans Affairs Methicillin Resistant Staphylococcus Aureus (MRSA) Pneumonia Cohort Treated With Linezolid Or Vancomycin
In Brief
An observational study evaluating linezolid (Zyvox) and vancomycin for Pneumonia. Completed, enrolled 5,271 participants.
Detailed Summary
The purpose of this non-interventional, retrospective study of existing data is to evaluate clinical outcomes related to Methicillin-resistant Staphylococcus aureus hospital based pneumonia by treatment and among subpopulations.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPneumonia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
Primary CompletionJan 2013
First PostedMar 2013
TodayJul 2026
First PostedMar 28, 2013
Enrollment StartDec 1, 2012
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 13.3 years ago
Interventions
linezolid (Zyvox)drug
As prescribed-this is retrospective cohort of existing clinical data.
vancomycindrug
As prescribed-this is retrospective cohort of existing clinical data.